Proof-of-concept study of palovarotene in patients with emphysema secondary to alpha-1-antitrypsin deficiency
Latest Information Update: 22 Jan 2014
At a glance
- Drugs Palovarotene (Primary)
- Indications Alpha 1-antitrypsin deficiency; Emphysema
- Focus Therapeutic Use
- Acronyms REPAIR
- 22 Jan 2014 New trial record
- 01 Aug 2012 Primary endpoint 'Pulmonary-function' has not been met.